南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (9): 2023-2034.doi: 10.12122/j.issn.1673-4254.2026.09.03

• • 上一篇    

逍遥散通过SKN-1抗氧化通路改善秀丽隐杆线虫帕金森病模型α-突触核蛋白聚集和神经元损伤

叶丽旋1(), 廖雨欣2, 刘琼2, 张佳2, 高磊2, 董钊扬1()   

  1. 1.广州中医药大学护理学院,广东 广州 510006
    2.南方医科大学中医药学院,广东 广州 510515
  • 收稿日期:2026-01-20 出版日期:2026-09-20 发布日期:2026-09-30
  • 通讯作者: 董钊扬 E-mail:2669556676@qq.com;021092@ gzucm.edu.cn
  • 作者简介:叶丽旋,在读硕士研究生,E-mail: 2669556676@qq.com
  • 基金资助:
    国家自然科学基金(82004091);广州市科技计划基础与应用基础研究专题(SL2024A04J01591);广州中医药大学固本工程一级学科能力提升项目(GZY2025GB0920)

Xiaoyao San alleviates abnormal α‑syn aggregation and neuronal injury in a Caenorhabditis elegans model of Parkinson disease via the SKN-1 antioxidative pathway

Lixuan YE1(), Yuxin LIAO2, Qiong LIU2, Jia ZHANG2, Lei GAO2, Zhaoyang DONG1()   

  1. 1.School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
    2.School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
  • Received:2026-01-20 Online:2026-09-20 Published:2026-09-30
  • Contact: Zhaoyang DONG E-mail:2669556676@qq.com;021092@ gzucm.edu.cn
  • Supported by:
    National Natural Science Foundation of China(82004091)

摘要:

目的 探讨逍遥散(XYS)在秀丽隐杆线虫(C. elegans)帕金森病(PD)模型中的神经保护作用及其分子机制。 方法 采用6-羟基多巴胺(6-OHDA)诱导建立PD线虫模型,并结合α-突触核蛋白(α-syn)过表达转基因虫株(NL5901)进行验证。将线虫分为对照组、模型组及XYS低(25 μg/mL)、中(50 μg/mL)、高(100 μg/mL)剂量组。通过生存曲线分析评估寿命;采用20 s内身体弯曲次数及基础减慢反应分别评价线虫的运动功能和食物相关行为;利用GFP标记的转基因虫株观察多巴胺能神经元损伤及α-syn聚集水平;采用二氢乙啶荧光探针(DHE)检测体内活性氧(ROS)水平,并结合RT-qPCR分析dat-1、cat-2、ced-9、gst-4及sod-3等相关基因表达;通过RNA干扰(RNAi)沉默skn-1表达,以验证XYS作用是否依赖于SKN-1/Nrf2信号通路。 结果 XYS可显著延长PD模型线虫寿命(P<0.001),增加第5天和第10天的20 s内身体弯曲次数(P<0.05),并改善基础减慢反应(P<0.05);XYS可减轻6-OHDA诱导的多巴胺能神经元损伤,提高dat-1、cat-2及ced-9表达水平(P<0.05),并降低α-syn聚集水平(P<0.001)。此外,XYS处理后降低ROS水平(P<0.05),sod-3及gst-4等抗氧化相关基因表达上调(P<0.05)。机制研究显示,XYS可增强skn-1::GFP及sod-3::GFP荧光信号(P<0.05)。在skn-1 RNAi条件下,脂质含量下降(P<0.05),且XYS对上述改变无明显改善作用(P>0.05);同时,XYS对sod-3::GFP荧光降低的恢复作用消失(P>0.05)。 结论 XYS可减轻氧化应激并抑制α-syn异常聚集,从而改善秀丽隐杆线虫PD模型神经功能,其作用可能与SKN-1/Nrf2相关抗氧化通路有关。

关键词: 逍遥散, 帕金森病, 多巴胺能神经元, 6-羟基多巴胺, α-突触核蛋白, 秀丽隐杆线虫

Abstract:

Objective To investigate the neuroprotective effects of XiaoyaoSan (XYS) in a Caenorhabditis elegans (C. elegans) model of Parkinson disease (PD) and explore its molecular mechanism. Methods A PD model was established in C. elegans using 6-hydroxydopamine (6-OHDA) and validated using a transgenic strain overexpressing α‑synuclein (α‑syn) (NL5901). The worms were treated with 25, 50 or 100 μg/mL XYS, and their lifespan was recorded. Their motor function and food-related behaviors were evaluated by counting body bends within 20 s and observing the basal slowing response. Dopaminergic neuron degeneration and α‑syn aggregation were observed in GFP-labeled transgenic worms. Intracellular ROS levels were measured using a DHE fluorescent probe, and the mRNA expressions of dat-1, cat-2, ced-9, gst-4, and sod-3 were analyzed using RT-qPCR. RNA interference (RNAi) was employed to knock down skn-1 expression to determine whether the effects of XYS depend on the SKN-1/Nrf2 signaling pathway. Results XYS significantly prolonged the lifespan of PD model worms, increased their body bends within 20 s on day 5 and day 10, and improved the basal slowing response. XYS obviously alleviated 6-OHDA-induced dopaminergic neuronal damage, upregulated the expression of dat-1, cat-2, and ced-9, and reduced α‑syn accumulation. Treatment with XYS decreased reactive oxygen species (ROS) levels and upregulated the antioxidant-related genes including sod-3 and gst-4. Mechanistic studies showed that XYS significantly enhanced skn-1::GFP and sod-3::GFP fluorescence signals. Knocking down skn-1 resulted in decreased lipid content in the worms, and XYS failed to significantly reverse this change; skn-1 knockdown also abolished the restorative effect of XYS on sod-3::GFP fluorescence reduction. Conclusion XYS improves neurological function in Caenorhabditis elegans PD model by alleviating oxidative stress and suppressing abnormal α‑syn aggregation, and its neuroprotective effect is mediated probably by the SKN-1/Nrf2-related antioxidant pathway.

Key words: Xiaoyao San, Parkinson disease, dopaminergic neurons, 6-hydroxydopamine, α-synuclein, C. elegans